Clinical Trials for Blood conditions

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

• Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
• Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
• Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
• Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Blood conditions is grouped into the following categories:-

• View by trial name
• View by drugs used in Blood conditions clinical trials

Clinical Trials by trial name

The format for each of the following is:

• The name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.
• followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Blood conditions:

• Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial - preeclampsia
• Calcium for Pre-Eclampsia Prevention (CPEP) - preeclampsia
• Oral Calcium in Pregnant Women With Hypertension - preeclampsia
• Renin and Prorenin in Pregnancy - preeclampsia
• Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia - preeclampsia
• Prevention of Pre-Term Birth by Treatment of Periodontal Disease - preeclampsia
• Efficacy Study of Digibind for Treatment of Severe Preeclampsia - preeclampsia
• Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction - preeclampsia
• Prospective Study in Pregnant Women With Hypercoagulopathy - preeclampsia
• Glomerular Injury of Preeclampsia - preeclampsia
• The Relaxation and Blood Pressure in Pregnancy (REBIP) Study - preeclampsia
• Evaluation of the Safety of Relaxin in Severe Preeclampsia - preeclampsia
• Antioxidant Therapy to Prevent Preeclampsia - preeclampsia
• Cardiovascular and Autonomic Reactivity in Women With a History of Pre-Eclampsia - preeclampsia
• Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS) - preeclampsia
• Prevalence Study of Sleep Apnea in Women With Preeclampsia - preeclampsia
• LMWH to Prevent Preeclampsia and Fetal Growth Restriction - preeclampsia
• Mechanism of Thrombocytopenia in Infants - preeclampsia
• Abbreviated MgSO4 Therapy in Post-Partum Preeclampsia - preeclampsia
• Family Study on Preeclampsia - preeclampsia
• Antioxidant Supplementation in Pregnant Women With Low Antioxidant Status - preeclampsia
• Hypertonic Saline Use in Preeclampsia - preeclampsia
• Angiotensinogen Variants and Adverse Pregnancy Outcomes - preeclampsia
• Hypertensive and Normal Pregnancy--Calcium Metabolism and Renin-Angiotensin - SCOR in Hypertension - preeclampsia
• Sildenafil Citrate for the Treatment of Established Pre-Eclampsia - preeclampsia
• L-Arginine in Pre-Eclampsia - preeclampsia
• Disease Modification in Toxaemia of Pregnancy. - preeclampsia
• Endothelial and Left Ventricular Function in Preeclampsia - preeclampsia
• the Implications of Pathogenesis of Pre-Eclampsia - preeclampsia
• ECLAXIR:Search for an Association Between CX3CR1 V249I Polymorphism, Preeclampsia and Endothelial Injury - preeclampsia
• Hemodynamic Measurements in Women With Serious Preeclampsia - preeclampsia
• Coenzyme Q10 Supplementation and Development of Preeclampsia - preeclampsia
• Leptin and Cytokines in Diabetic Pregnancy - Physiologic or Pathogenic Role - preeclampsia
• Regulation of Placental Vascular Reactivity in Pregnancy-Induced Hypertension - preeclampsia
• Treatment Targets for Chronic Hypertension in Pregnancy - preeclampsia
• Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence. - preeclampsia

Drugs used in Clinical Trials for Blood conditions

The format for each of the following is:

• The drug,
• followed by the name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Blood conditions:

• 2% buffered hypertonic saline administration - preeclampsia
• Abbreviation Of Magnesium Sulfate Therapy (12 Hours Versus The Traditional 24 Hours After Delivery) - preeclampsia
• Alpha Methyldopa - preeclampsia
• Anti-digoxin antibody (FAB fragment) - preeclampsia
• Calcium - preeclampsia
• Calcium - preeclampsia
• Clonidine - preeclampsia
• Coenzyme Q10 - preeclampsia
• Dalteparin - preeclampsia
• Epidural ropivacaine - preeclampsia
• L-Arginine Supplementation - preeclampsia
• L-arginine - preeclampsia
• Labetalol (Seizure Prevention) - preeclampsia
• Labetalol - preeclampsia
• Magnesium Sulfate - preeclampsia
• Methyldopa - preeclampsia
• MgSO4 (seizure prevention) - preeclampsia
• Nifedipine - preeclampsia
• Nimodipine - preeclampsia
• Recombinant Human Relaxin - preeclampsia
• Recombinant human activated protein C or drotrecogin alpha - preeclampsia
• Sildenafil citrate - preeclampsia
• Vitamin C 1000mg and E 400IU - preeclampsia
• Vitamin C and E - preeclampsia
• Vitamins C and E or placebo - preeclampsia

The trial data on this page has been sourced from

• The U.S. National Library of Medicine (NLM) together with ClinicalTrials.gov

 » Next page: External links relating to Blood conditions

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

• External links relating to Blood conditions
• Diarrhea – Chronic, No Blood or Weight Loss (In A Page: Pediatric Signs and Symptoms)
• Blood pressure increase [Hypertension] (Handbook of Signs & Symptoms (Third Edition))
• Blood pressure decrease [Hypotension] (Handbook of Signs & Symptoms (Third Edition))
• Acute leukemia (Professional Guide to Diseases (Eighth Edition))

Tools & Services:

• Bookmark this page
• Take a survey relating to Blood conditions
• Symptom Search
• Symptom Checker
• Medical Dictionary
• Give your feedback

Medical Articles:

• Disease & Treatments Search
• Misdiagnosis Center
• Full list of interesting articles

Forums & Message Boards

• Ask or answer a question at the Boards:
• I cannot get a diagnosis. Please help.
• Tell us your medical story.
• Share your misdiagnosis story.
• What is the best treatment for my condition?
• See all the Boards.

Enter your search terms Submit search form
Search The Web Search wrongdiagnosis.com

Common Health Mistakes

Symptom
Checker

Search Specialists by State and City